Application: The 1.5T Magnetic Resonance Imaging (MRI) market is principally driven by its deployment across distinct clinical applications, each contributing uniquely to total market volume. Neurology accounts for the largest share, reflecting the modality’s superior soft‑tissue contrast for brain and spinal cord assessment, which underpins diagnoses of stroke, multiple sclerosis, and neurodegenerative disorders. Cardiology follows, leveraging 1.5T systems for cardiac function and perfusion imaging, particularly in facilities where higher‑field 3T scanners are cost‑prohibitive. Orthopedics utilizes the technology for musculoskeletal evaluations, including joint, cartilage, and ligament visualization, supporting surgical planning and post‑operative monitoring. Oncology benefits from functional sequences such as diffusion‑weighted imaging to characterize tumor biology and treatment response. Finally, General Imaging—covering abdominal, pelvic, and whole‑body scans—provides a broad base of routine examinations. Collectively, these application segments shape the overall market size, with their proportional influence captured in the accompanying pie‑chart, illustrating the relative weight of each clinical domain in 1.5T MRI adoption.